In humans, OI is genetically heterogeneous, with approximately 90% of cases resulting from mutations of the COL1A1 or COL1A2 genes, which encode procollagen molecules of collagen type I and lead to its quantitative and qualitative abnormalities (6). This evidence concerns the gene COL1A2 and osteogenesis imperfecta.